1. Home
  2. RILYL vs MDAIW Comparison

RILYL vs MDAIW Comparison

Compare RILYL & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RILYL

B. Riley Financial Inc.

N/A

Current Price

$12.39

Market Cap

0.0

Sector

Finance

ML Signal

N/A

MDAIW

Spectral AI Inc.

N/A

Current Price

$0.70

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RILYL
MDAIW
Founded
N/A
N/A
Country
United States
United States
Employees
2056
78
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RILYL
MDAIW
Price
$12.39
$0.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.8K
8.1K
Earning Date
N/A
02-27-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,264,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
44.52
52 Week Low
$1.77
$0.26
52 Week High
$14.80
$1.01

Technical Indicators

Market Signals
Indicator
RILYL
MDAIW
Relative Strength Index (RSI) 56.27 71.17
Support Level $9.51 $0.66
Resistance Level $13.00 $0.86
Average True Range (ATR) 0.68 0.03
MACD -0.10 0.01
Stochastic Oscillator 44.26 73.40

Price Performance

Historical Comparison
RILYL
MDAIW

About RILYL B. Riley Financial Inc.

BRC Group Holdings Inc is a diversified holding company, including financial services, telecom, and retail, and investments in equity, debt and venture capital.

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: